Summary:
Between 1995 and 2002, nine cases of nontuberculous mycobacterium (NTM) were isolated from 462 allogeneic stem cell transplant (SCT) recipients (1.9%), and none from 139 autologous cases. They included three cases each of Mycobacterium fortuitum and M. chelonae, and single cases of M. scrofalaceum, M. gordonnae and M. avium complex. Seven cases were respiratory, including five cases requiring treatment, and two involved infected catheters and vascular conduits. Compared with nine cases of mycobacterium tuberculosis (MTB) isolated in the same period, NTM isolation occurred later after HSCT and involved more unrelated donors. Important risk factors for NTM infection included significant aGVHD (P=0.043), leukemia relapse (P=0.022), MUD and mismatch SCT (P<0.001) and existence of BO (P<0.001). Coinfection with aspergillus was common. Invasive NTM disease required prolonged antimicrobial treatment in five cases due to M. fortuitum and M. chelonae. With better MTB prophylaxis, intensive immunosuppression and better awareness, NTM has become an emerging threat in oriental allogeneic HSCT recipients. The cutoff between colonization and infection, and the threshold for starting treatment is unclear. NTM isolation is a marker for severe immunosuppression and poor prognosis. When there is doubt over species identity or extent of infection, broad-spectrum cover may be prudent.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Patel R, Roberts GD, Keating MR, Paya CV . Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994; 19: 263–273.
Chan JC, So SY, Lam WK, Ip MS . High incidence of pulmonary tuberculosis in the non-HIV infected immunocompromised patients in Hong Kong. Chest 1989; 96: 835–839.
Yuen KY, Woo PC . Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 2002; 20: 51–62.
Martino R, Martinez C, Brunet S et al. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996; 18: 809–812.
Aljurf M, Gyger M, Alrajhi A et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999; 24: 551–554.
Budak-Alpdogan T, Tangun Y, Kalayoglu-Besisik S et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000; 6: 370–374.
George B, Mathews V, Srivastava V et al. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2001; 27: 973–975.
Ozkaynak MF, Lenarsky C, Kohn D, Weinberg K, Parkman R . Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children. Am J Pediatr Hematol Oncol 1990; 12: 220–224.
Mohite U, Das M, Saikia T et al. Mycobacterial pulmonary infection post allogeneic bone marrow transplantation. Leuk Lymphoma 2001; 40: 675–678.
Gaviria JM, Garcia PJ, Garrido SM et al. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant 2000; 6: 361–369.
Kurzrock R, Zander A, Vellekoop L et al. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984; 77: 35–40.
Roy V, Weisdorf D . Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19: 467–470.
Au WY, Lie AK, Ma SK et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia: a single-centre experience. Hematol Oncol 1998; 16: 163–168.
Lee CK, Lie AK, Liang R et al. Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT). Am J Hematol 1999; 61: 85–89.
Au WY, Lie AK, Kwong YL et al. Allogeneic bone marrow transplantation for severe aplastic anemia: the Hong Kong scenario. Hematol Oncol 1998; 16: 41–46.
Au WY, Chan AC, Lie AK et al. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 1998; 21: 205–208.
Ip MS, Yuen KY, Woo PC et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998; 158:1173–1177.
Leung AY, Suen CK, Lie AK et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971–1978.
Metchock BG, Nolte FS, Wallace RJJ . Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, (eds). Manual of Clinical Microbiology, 7th edn. American Society for Microbiology: Washington, DC, 1999.
Yam WC, Yuen KY, Seto WH . Direct detection of Mycobacterium tuberculosis in respiratory specimens using an automated DNA amplification assay and a single tube nested polymerase chain reaction (PCR). Clin Chem Lab Med 1998; 36: 597–599.
Annonymous. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156(Part 2): S1–S25.
Au WY, Fung A, Man C et al. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. Br J Haematol 2003; 120: 1062–1065.
Annonymous. Notification and death rates of tuberculosis 1946–2001. Tropical Health Report, Deparment of Health, Hong Kong, 2002, vol. 2, pp 49–50.
Hosker HS, Lam CW, Ng TK et al. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995; 89: 3–8.
Low K, Lee SS . The pattern of AIDS reporting and the implications on HIV surveillance. Public Health Epidemiol Bull, Hong Kong 2002; 11: 41–49.
Navari RM, Sullivan KM, Springmeyer SC et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36: 509–513.
Olivier KN, Yankaskas JR, Knowles MR . Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect 1996; 11: 272–284.
Yuen KY, Chan KS, Chan CM et al. Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis. J Clin Pathol 1993; 46: 318–322.
Griffith DE . Risk–benefit assessment of therapies for Mycobacterium avium complex infections. Drug Saf 1999; 21: 137–152.
Peters EJ, Morice R . Miliary pulmonary infection caused by Mycobacterium terrae in an autologous bone marrow transplant patient. Chest 1991; 100: 1449–1450.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Au, W., Cheng, V., Ho, P. et al. Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transplant 32, 709–714 (2003). https://doi.org/10.1038/sj.bmt.1704210
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704210
Keywords
This article is cited by
-
Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients
International Journal of Hematology (2015)
-
Update on Nontuberculous Mycobacterial Infections in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
Current Infectious Disease Reports (2014)
-
Mycobacterial infections in adult patients with hematological malignancy
European Journal of Clinical Microbiology & Infectious Diseases (2012)